Thyroid Antibodies for Differentiating Graves' Disease from Hashimoto's Thyroiditis
To differentiate Graves' disease from Hashimoto's thyroiditis, order TSH receptor antibodies (TRAb), thyroid peroxidase antibodies (TPOAb), and thyroglobulin antibodies (TgAb); TRAb positivity strongly suggests Graves' disease, while dual positivity of TPOAb and TgAb with negative or low TRAb indicates Hashimoto's thyroiditis.
Antibody Testing Strategy
Primary Differentiating Antibodies
- TRAb (TSH Receptor Antibodies) is the hallmark antibody for Graves' disease, with 83.67% positivity in Graves' patients versus only 13.64% in Hashimoto's hyperthyroidism 1
- TPOAb and TgAb combined provide the strongest diagnostic pattern for Hashimoto's thyroiditis, with dual positivity in 86.36% of Hashimoto's cases compared to 48.98% in Graves' disease 1
- The combination of these three antibodies (TRAb, TPOAb, TgAb) provides superior diagnostic accuracy compared to testing any single antibody 2
Specific Antibody Patterns
For Graves' Disease:
- TRAb positivity is present in approximately 84% of cases 1
- TPOAb is positive in 75-87% of cases 1, 3
- TgAb is positive in 48-73% of cases 1, 3
- Higher FT3 levels (16.13 ± 9.95) correlate with TRAb positivity 1
For Hashimoto's Thyroiditis:
- TPOAb and TgAb dual positivity occurs in 86% of cases 1
- TRAb is typically negative or low (positive in only 13.64%) 1
- TPOAb alone shows 86% positivity 3
- TgAb alone shows 58% positivity 3
Clinical Algorithm for Interpretation
When TRAb is Elevated:
- Strongly suggests Graves' disease, particularly when combined with suppressed TSH and elevated free T3 1, 4
- TRAb levels correlate with disease activity and can predict treatment response 4
- Radioactive iodine uptake scan can confirm diagnosis by distinguishing Graves' from destructive thyroiditis 5
When TPOAb and TgAb are Both Positive with Low/Negative TRAb:
- Indicates Hashimoto's thyroiditis with 86% specificity 1
- This pattern defines thyroid autoimmunity even in euthyroid patients 4
- Predicts higher risk of progression to hypothyroidism 4
When All Three Antibodies are Positive:
- More likely Graves' disease if TRAb is significantly elevated (>40 IU/L) 1
- Consider overlap syndrome or potential conversion between conditions 6, 7
- Monitor closely as 15-20% of Graves' patients may develop Hashimoto's over time 8
Important Caveats
Measurement Limitations:
- Blocking TSH receptor antibodies (TSBAb) may be present in Hashimoto's causing atrophic thyroiditis, but stimulating antibodies in Graves' disease can overwhelm their detection in current bioassays 9
- This technical limitation means that blocking antibodies may be underdiagnosed in clinical practice 9
Diagnostic Model Enhancement:
- Adding clinical variables (gender, FT3 or FT4 levels) to antibody testing improves diagnostic accuracy 2
- A diagnostic model including FT4, TGAb, TPOAb, TRAb, and gender achieved an area under the ROC curve of 0.806 for differentiating these conditions 2
- Including radioactive iodine uptake (2-hour and 24-hour) further improves accuracy to 0.843 2
Rare Conversion Phenomenon:
- Approximately 15-20% of Graves' patients may convert to Hashimoto's hypothyroidism over time 8
- Conversion from Hashimoto's to Graves' is rare but possible, occurring in patients who require frequent levothyroxine dose reductions 6, 7
- TSAb monitoring in Hashimoto's patients, particularly those who are TSAb-positive, may help predict conversion to Graves' disease 7